African Journal of Traditional Complementary and Alternative Medicines · 2013 · 18 citations · 5 references
MedicineImmunologyOncologyCancer ImmunologyHypersensitivityTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyOncology PharmacologyT Cell Responses To TumorsAdaptive Immune FunctionAnticancer ActivityAntitumor Immune ActivationImmune Function ImpairmentImmune Function IndicatorsInnate Antitumor ImmunityT-cell Responses To Tumor Antigens
We investigated the anti-tumor effects of Verbena officinalis extract on H22 tumor-bearing mice and its effect on immune function. Mice model of H22 solid tumor was established, the mice were divided into five groups and administered the extract, later, tumors were removed and inhibition rates were calculated; spleens were removed and spleen indices were calculated, and the sheep red blood cell-delayed-type hypersensitivity (SRBC-DTH) and the serum hemolysin level were determined. The Verbena officinalis extract had anti-tumor effect, with the inhibition rate reaching 38.78%, it also increased the spleen index to a certain extent, in addition, the changes in DTA and HA were not obvious compared with the model group. The Verbena officinalis extract had in vivo anti-tumor effect, while causing no damage on the immune function.
5
A new triterpenoid from<i>Verbena officinalis</i>L.
Jicheng Shu, Jianqun Liu, Gui‐Xin Chou · Natural Product Research · 2012 · 20 citations
Khaled A. Abdelshafeek, Adnan A Elgattar, Aziza H Zarkoon et al. · Asian Pacific Journal of Tropical Medicine · 2010 · 15 citations · Full text
Two new secoiridoid glycosides from <i>Verbena officinalis</i>
Wei Xu, Fei Xin, Sha Yi et al. · Journal of Asian Natural Products Research · 2010 · 10 citations